Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling jak2'

Search results for: 'research area jak stat signaling jak2'

Items 21-30 of 128

Page
per page
  1. FH535
    A3413 FH535
    Summary: Wnt/B-catenin inhibitor
      ≥36.1 mg/mL
  2. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
  3. SB 203580
    A8254 SB 203580
     9 Citation
    Target: p38|PKB
    Summary: P38 MAP kinase inhibitor
      insoluble in H2O; ≥18.872 mg/mL
  4. Tofacitinib (CP-690550,Tasocitinib)
    A4138 Tofacitinib (CP-690550,Tasocitinib)
     1 Citation
    Target: JAK
    Summary: Janus kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL
  5. Bardoxolone methyl
    A3221 Bardoxolone methyl
    Target: Nrf2
    Summary: IKK inhibitor, potent antioxidant inflammation modulator
      ≥25.3 mg/mL
  6. ICG 001
    A8217 ICG 001
     1 Citation
    Summary: Wnt/β-catenin pathway inhibitor
      ≥27.43 mg/mL
  7. LDN-193189
    A8324 LDN-193189
    Target: BMP and Other Activin Receptors
    Summary: ALK inhibitor,potent and selective
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  8. LY2940680
    A8651 LY2940680
    Target: Smoothened receptor
    Summary: Hedgehog/SMO antagonist,inhibits Hh signaling
  9. SB-505124 hydrochloride
    A3799 SB-505124 hydrochloride
    Target: ALK
    Summary: ALK5/ALK4/ALK7 inhibitor in TGF-β/activin signalling,selective
  10. TAK-632
    A8226 TAK-632
    Target: Raf
    Summary: Pan-RAF inhibitor,potent and selective
      ≥27.75 mg/mL

Items 21-30 of 128

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 127item
  2. Natural Products 1 item
Specificity
  1. Selective 87item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 7item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Akt 9item
  3. PI3K 13item
  4. Raf 8item
  5. Aurora Kinases 2item
  6. mTOR 8item
  7. Androgen Receptors 1 item
  8. FLT3 2item
  9. GSK-3 6item
  10. P-glycoprotein (P-gp) 1 item
  11. VEGFR 6item
  12. PDGFR 1 item
  13. Phosphodiesterases (PDEs) 1 item
  14. p38 4item
  15. PKB 1 item
  16. JNK 2item
  17. MEK 4item
  18. PORCN 1 item
  19. FGFR 2item
  20. Nrf2 1 item
  21. GABAB Receptors 1 item
  22. Smoothened 1 item
  23. Src 1 item
  24. Trk Receptors 1 item
  25. NMDA Receptors 1 item
  26. STAT 7item
  27. EGFR 4item
  28. Hedgehog 1 item
  29. BMP and Other Activin Receptors 2item
  30. JAK 17item
  31. Syk 2item
  32. DNA-PK 1 item
  33. HSP90 1 item
  34. TNKS 1 item
  35. Toll-like receptors (TLRs) 1 item
  36. ERK 2item
  37. PKC 6item
  38. Melanocortin (MC) Receptors 1 item
  39. ALK 2item
  40. PKG 1 item
  41. PKA 4item
  42. Fatty-acid-binding proteins (FABPs) 1 item
  43. RSK 1 item
  44. Histamine H1 Receptors 1 item
  45. MNK 1 item
  46. NO Donors / Precursors 1 item
  47. IL Receptors 1 item
  48. AChE 1 item
  49. BACE 1 item
  50. c-RET 1 item
  51. p70 rsk 1 item
  52. Smoothened receptor 1 item
  53. Antibiotic 1 item
  54. Prk 1 item
  55. ICAM 1 item
  56. Rho 1 item
  57. TYK2 2item
  58. MUSK 1 item
  59. MAP3K 1 item
  60. Thrombin Receptor 1 item
  61. prolactin secretion 1 item
  62. gonadotropin release 1 item
  63. TRPC channel 1 item
  64. FKBP 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Bladder Cancer 1 item
  4. Breast Cancer 19item
  5. Cancer 80item
  6. Cervical Cancer 2item
  7. Colon Cancer 8item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 10item
  10. Glioblastoma 10item
  11. Glioma 3item
  12. Heart Failure 1 item
  13. HIV Infections 1 item
  14. Immunological Diseases 1 item
  15. Inflammatory Bowel Disease 1 item
  16. Leukemia 9item
  17. Liver Cancer 1 item
  18. Lung Cancer 7item
  19. Lymphoma 3item
  20. Melanoma 6item
  21. Multiple Myeloma 1 item
  22. Myelofibrosis 1 item
  23. Myeloma 1 item
  24. Neuroblastoma 2item
  25. Non-small Cell Lung Cancer 5item
  26. Ovarian Cancer 7item
  27. Pancreatic Cancer 9item
  28. Pancreatic Carcinoma 2item
  29. Prostate Cancer 11item
  30. Psoriasis 1 item
  31. Pulmonary Arterial Hypertension 1 item
  32. Pulmonary Fibrosis 1 item
  33. Renal Cancer 1 item
  34. Renal Cell Carcinoma 1 item
  35. Rheumatoid Arthritis 4item
  36. Thyroid Cancer 3item
  37. Type 2 Diabetes 2item